Top Pipeline Therapies Shaping the Future of Nonalcoholic Steatohepatitis Treatments
Nonalcoholic Steatohepatitis (NASH) is a severe liver condition characterized by inflammation and fat buildup, which can lead to fibrosis, cirrhosis, and even liver cancer. The Nonalcoholic Steatohepatitis Treatment market has grown considerably in recent years due to the rising incidence of obesity, diabetes, and metabolic syndrome—key risk factors associated with the disease. As the medical…